<DOC>
	<DOCNO>NCT00734292</DOCNO>
	<brief_summary>The primary purpose study evaluate early bronchodilating effect SKP FlutiForm HFA pMDI compare placebo .</brief_summary>
	<brief_title>Single-dose Crossover Study Evaluate Early Bronchodilating Effect FlutiForm HFA pMDI Adult Subjects With Mild Moderate Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Subjects document history mild moderate asthma currently take stable dose inhale corticosteroid Participation prior FlutiForm study Smoking history within last 12 month , Significant , nonreversible , pulmonary disease Lifethreatening asthma within last year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Asthma Mild Moderate</keyword>
</DOC>